baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

HSBC TUR.WAR.OP.END. CPW/ DE000HS2VA78 /

30/05/2024 09:36:16	Chg.0.0000	Bid10:20:12	Ask10:20:12	Underlying	Strike price	Expiration date	Option type
0.1400EUR	0.00%	0.1200 Bid Size: 40,000	0.1400 Ask Size: 40,000	Check Point Software...	136.3529 USD	31/12/2078	Call

GlobeNewswire 29/05 DEADLINE ALERT for LUNA, HRT, and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class ...

GlobeNewswire 29/05 DEADLINE ALERT for HRT, CKPT, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class ...

GlobeNewswire 29/05 UPDATE -- Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of L...

GlobeNewswire 29/05 ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference

GlobeNewswire 29/05 Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch

GlobeNewswire 29/05 Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology...

GlobeNewswire 29/05 Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KI...

GlobeNewswire 29/05 Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR ...

GlobeNewswire 29/05 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study

GlobeNewswire 28/05 NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual ...

GlobeNewswire 28/05 7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with...

GlobeNewswire 28/05 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkp...

GlobeNewswire 28/05 Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Tril...

GlobeNewswire 28/05 TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024

GlobeNewswire 27/05 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel...

GlobeNewswire 27/05 CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. ...

GlobeNewswire 24/05 CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenaden...

GlobeNewswire 23/05 Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-10...

GlobeNewswire 23/05 BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...

GlobeNewswire 23/05 I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...

GlobeNewswire 23/05 NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...

GlobeNewswire 23/05 Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...

GlobeNewswire 23/05 Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...

GlobeNewswire 23/05 Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...

GlobeNewswire 23/05 Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...

HSBC TUR.WAR.OP.END. CPW/ DE000HS2VA78 /

If you wish to receive reply to your feedback, please provide your email address.